Kuzmanovszki, D.; Kiss, N.; Tóth, B.; Tóth, V.; Szakonyi, J.; Lőrincz, K.; Hársing, J.; Kuroli, E.; Imrédi, E.; Kerner, T.;
et al. Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study. J. Clin. Med. 2023, 12, 5966.
https://doi.org/10.3390/jcm12185966
AMA Style
Kuzmanovszki D, Kiss N, Tóth B, Tóth V, Szakonyi J, Lőrincz K, Hársing J, Kuroli E, Imrédi E, Kerner T,
et al. Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study. Journal of Clinical Medicine. 2023; 12(18):5966.
https://doi.org/10.3390/jcm12185966
Chicago/Turabian Style
Kuzmanovszki, Daniella, Norbert Kiss, Béla Tóth, Veronika Tóth, József Szakonyi, Kende Lőrincz, Judit Hársing, Enikő Kuroli, Eleonóra Imrédi, Tünde Kerner,
and et al. 2023. "Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study" Journal of Clinical Medicine 12, no. 18: 5966.
https://doi.org/10.3390/jcm12185966
APA Style
Kuzmanovszki, D., Kiss, N., Tóth, B., Tóth, V., Szakonyi, J., Lőrincz, K., Hársing, J., Kuroli, E., Imrédi, E., Kerner, T., Patyánik, M., Wikonkál, N. M., Szabó, Á., Brodszky, V., Rencz, F., & Holló, P.
(2023). Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study. Journal of Clinical Medicine, 12(18), 5966.
https://doi.org/10.3390/jcm12185966
